The current use and evolving landscape of nutraceuticals

AS Chopra, R Lordan, OK Horbańczuk… - Pharmacological …, 2022 - Elsevier
The nutraceutical market is currently a high-impact multi-billion-dollar industry, and it is
anticipated to grow rapidly over the next decade. Nutraceuticals comprise diverse food …

[HTML][HTML] Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information

HM Rando, TD Bennett, JB Byrd, C Bramante… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Since late 2019, the novel coronavirus SARS-CoV-2 has introduced a wide array of health
challenges globally. In addition to a complex acute presentation that can affect multiple …

Notable developments for vitamin D amid the COVID-19 pandemic, but caution warranted overall: a narrative review

R Lordan - Nutrients, 2021 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel contagion
that has infected over 113 million people worldwide. It is responsible for the coronavirus …

The role of 14‐3‐3 proteins in cell signalling pathways and virus infection

J Liu, S Cao, G Ding, B Wang, Y Li… - Journal of Cellular …, 2021 - Wiley Online Library
3‐3 proteins are highly conserved in species ranging from yeast to mammals and regulate
numerous signalling pathways via direct interactions with proteins carrying phosphorylated …

Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?

S Brahma, A Naik, R Lordan - Clinical Nutrition ESPEN, 2022 - Elsevier
Since the global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), research has focused on understanding the etiology of coronavirus disease 2019 …

Network for network concept offers new insights into host-SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs

N Eskandarzade, A Ghorbani, S Samarfard… - Computers in biology …, 2022 - Elsevier
Abstract SARS-CoV-2, the causal agent of COVID-19, is primarily a pulmonary virus that can
directly or indirectly infect several organs. Despite many studies carried out during the …

COVID-19 molecular pathophysiology: acetylation of repurposing drugs

JH Lee, B Kanwar, A Khattak, J Balentine… - International Journal of …, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces immune-mediated
type 1 interferon (IFN-1) production, the pathophysiology of which involves sterile alpha …

[HTML][HTML] COVID-19 associated liver injury: an updated review on the mechanisms and management of risk groups

Y Shi, M Wang, L Wu, X Li, Z Liao - Liver Research, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has been associated with various liver
injury cases worldwide. To date, the prevalence, mechanism, clinical manifestations …

Application of traditional vaccine development strategies to SARS-CoV-2

HM Rando, R Lordan, AJ Lee, A Naik, N Wellhausen… - Msystems, 2023 - Am Soc Microbiol
Over the past 150 years, vaccines have revolutionized the relationship between people and
disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have …

SARS-CoV-2 Affects Both Humans and Animals: What Is the Potential Transmission Risk? A Literature Review

A Santaniello, G Perruolo, S Cristiano, AL Agognon… - Microorganisms, 2023 - mdpi.com
In March 2020, the World Health Organization Department declared the coronavirus (COVID-
19) outbreak a global pandemic, as a consequence of its rapid spread on all continents. The …